Two longtime leaders in Hawaiʻi’s staffing industry are stepping into a new chapter—while staying rooted in the same local mission that has guided them for decades. Staffing Solutions of Hawaiʻi and ...

NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Array, a leading embeddable platform that complements the existing product experience for many of the world’s leading fintechs, financial institutions, and ...

We’ll explore how Array’s integration of APA’s fixed-tilt and A-frame designs opens new possibilities in difficult terrains and why foundation choice is critical to structural resilience and long-term ...

With global shipping responsible for 3% of greenhouse gases, one startup’s quicklime-powered tech promises to make cargo ships more climate-friendly, by turning exhaust fumes into harmless limestone ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Add Yahoo as a preferred source to see more of our stories on Google. A new report suggests increased investments in solar power on school grounds could help reduce energy costs in Centre County and ...

Array Technologies Inc. (NASDAQ:ARRY) is one of the best solar stocks to buy according to Wall Street analysts. On August 14, Array Technologies announced the successful completion of its acquisition ...

Management reiterated the goal to achieve positive free cash flow by Q4 2025, with McCormack stating, “we remain on track to deliver positive free cash flow by Q4 2025.” Beck indicated, “we still ...

Albuquerque-based Array Technologies reported Thursday a 20% jump in revenue from the previous quarter, beating analyst expectations. In an earnings call, company officials reported $362.2 million in ...

GUANGZHOU, China, July 2, 2025 /PRNewswire/ -- Bio-Thera Solutions, Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, today ...

Opus Genetics, Inc. announced positive topline results from its VEGA-3 Phase 3 clinical trial evaluating Phentolamine Ophthalmic Solution 0.75% for treating presbyopia, achieving its primary and key ...